Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
May 21, 2009
app pub date -
Oct 27, 2006
filing date -
Oct 27, 2005
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A growth of osteoclasts is inhibited by orally administering a liposomal lactoferrin. Thus a bone disease in which the osteoclast is involved is effectively prevented or treated by orally administering the liposomal lactoferrin. The present invention provides an osteoclast growth inhibitor, an oral composition and a preventive and therapeutic agent for bone diseases (osteoporosis, rheumatoid, periodontal diseases with alveolar bone resorption, which contain the liposomal lactoferrin, and a preventive or therapeutic method for the bone diseases. According to the present invention, the growth of the osteoclasts can be inhibited and the bone diseases due to promotion of the osteoclast growth can be prevented or treated.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully